DAXOR CORP (DXR) Fundamental Analysis & Valuation

NASDAQ:DXR • US2394671034

Current stock price

11.54 USD
+0.59 (+5.39%)
Last:

This DXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DXR Profitability Analysis

1.1 Basic Checks

  • In the past year DXR was profitable.
  • DXR had a positive operating cash flow in the past year.
  • In the past 5 years DXR has always been profitable.
  • In multiple years DXR reported negative operating cash flow during the last 5 years.
DXR Yearly Net Income VS EBIT VS OCF VS FCFDXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M

1.2 Ratios

  • DXR's Return On Assets of 19.93% is amongst the best of the industry. DXR outperforms 97.86% of its industry peers.
  • DXR's Return On Equity of 19.98% is amongst the best of the industry. DXR outperforms 93.58% of its industry peers.
Industry RankSector Rank
ROA 19.93%
ROE 19.98%
ROIC N/A
ROA(3y)7.4%
ROA(5y)11.66%
ROE(3y)7.44%
ROE(5y)12.51%
ROIC(3y)N/A
ROIC(5y)N/A
DXR Yearly ROA, ROE, ROICDXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of DXR (34343.82%) is better than 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of DXR has grown nicely.
  • DXR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 34343.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y147.98%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXR Yearly Profit, Operating, Gross MarginsDXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10K 20K 30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DXR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DXR has more shares outstanding
  • DXR has more shares outstanding than it did 5 years ago.
  • DXR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DXR Yearly Shares OutstandingDXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M
DXR Yearly Total Debt VS Total AssetsDXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • DXR has an Altman-Z score of 313.40. This indicates that DXR is financially healthy and has little risk of bankruptcy at the moment.
  • DXR has a Altman-Z score of 313.40. This is amongst the best in the industry. DXR outperforms 100.00% of its industry peers.
  • DXR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 313.4
ROIC/WACCN/A
WACCN/A
DXR Yearly LT Debt VS Equity VS FCFDXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • DXR has a Current Ratio of 0.08. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.08, DXR is doing worse than 96.79% of the companies in the same industry.
  • A Quick Ratio of 0.08 indicates that DXR may have some problems paying its short term obligations.
  • DXR has a Quick ratio of 0.08. This is amonst the worse of the industry: DXR underperforms 96.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
DXR Yearly Current Assets VS Current LiabilitesDXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DXR Growth Analysis

3.1 Past

  • DXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1068.54%, which is quite impressive.
  • Measured over the past years, DXR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.41% on average per year.
  • The Revenue for DXR has decreased by -77.71% in the past year. This is quite bad
  • DXR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.57% yearly.
EPS 1Y (TTM)1068.54%
EPS 3Y14.41%
EPS 5YN/A
EPS Q2Q%329.99%
Revenue 1Y (TTM)-77.71%
Revenue growth 3Y-51.22%
Revenue growth 5Y-36.57%
Sales Q2Q%-82.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.80% on average over the next years. This is quite good.
  • DXR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.38% yearly.
EPS Next Y-425%
EPS Next 2Y11.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year70%
Revenue Next 2Y72.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DXR Yearly Revenue VS EstimatesDXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
DXR Yearly EPS VS EstimatesDXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

4

4. DXR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.83 indicates a rather cheap valuation of DXR.
  • DXR's Price/Earnings ratio is rather cheap when compared to the industry. DXR is cheaper than 96.79% of the companies in the same industry.
  • DXR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.91.
  • The Forward Price/Earnings Ratio is negative for DXR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 5.83
Fwd PE N/A
DXR Price Earnings VS Forward Price EarningsDXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DXR indicates a somewhat cheap valuation: DXR is cheaper than 68.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 117.85
EV/EBITDA N/A
DXR Per share dataDXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DXR Dividend Analysis

5.1 Amount

  • No dividends for DXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DXR Fundamentals: All Metrics, Ratios and Statistics

DAXOR CORP

NASDAQ:DXR (4/28/2026, 8:26:01 PM)

11.54

+0.59 (+5.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04
Earnings (Next)N/A
Inst Owners1.45%
Inst Owner Change0%
Ins Owners5.2%
Ins Owner Change0.55%
Market Cap67.28M
Revenue(TTM)26.70K
Net Income(TTM)9.17M
Analysts80
Price Target22.95 (98.87%)
Short Float %0.11%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.57%
PT rev (3m)-4.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.83
Fwd PE N/A
P/S 2519.78
P/FCF 117.85
P/OCF 117.85
P/B 1.47
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)1.98
EY17.16%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.1
FCFY0.85%
OCF(TTM)0.1
OCFY0.85%
SpS0
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.7256 (62.27%)
Profitability
Industry RankSector Rank
ROA 19.93%
ROE 19.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 34343.82%
GM N/A
FCFM 2138.2%
ROA(3y)7.4%
ROA(5y)11.66%
ROE(3y)7.44%
ROE(5y)12.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y147.98%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 6.23%
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 313.4
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1068.54%
EPS 3Y14.41%
EPS 5YN/A
EPS Q2Q%329.99%
EPS Next Y-425%
EPS Next 2Y11.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-77.71%
Revenue growth 3Y-51.22%
Revenue growth 5Y-36.57%
Sales Q2Q%-82.71%
Revenue Next Year70%
Revenue Next 2Y72.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2121.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2121.4%
OCF growth 3YN/A
OCF growth 5YN/A

DAXOR CORP / DXR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAXOR CORP?

ChartMill assigns a fundamental rating of 4 / 10 to DXR.


Can you provide the valuation status for DAXOR CORP?

ChartMill assigns a valuation rating of 4 / 10 to DAXOR CORP (DXR). This can be considered as Fairly Valued.


What is the profitability of DXR stock?

DAXOR CORP (DXR) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DXR stock?

The Price/Earnings (PE) ratio for DAXOR CORP (DXR) is 5.83 and the Price/Book (PB) ratio is 1.47.


What is the earnings growth outlook for DAXOR CORP?

The Earnings per Share (EPS) of DAXOR CORP (DXR) is expected to decline by -425% in the next year.